140 related articles for article (PubMed ID: 3197254)
1. [Efficacy of Ro 15-0216 against human strains of Trypanosoma gambiense maintained in rodents. A preliminary study].
Richard-Lenoble D; Kombila MY; Felix H
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):609-15. PubMed ID: 3197254
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of experimental trypanosomiasis of sheep caused by Trypanosoma brucei brucei: efficacy of Ro 15-0216 (a 2-nitroimidazole derivative)].
Bouteille B; Darde ML; Pestre-Alexandre M; Dumas M; Breton JC; Nicolas JA; Catanzano G; Munoz M
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):616-22. PubMed ID: 3197255
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
[TBL] [Abstract][Full Text] [Related]
4. Trypanocidal activity of a 5-substituted 2-nitroimidazole compound (Ro 15-0216) in mice.
Zweygarth E; Röttcher D
Trop Med Parasitol; 1987 Sep; 38(3):171-4. PubMed ID: 3432951
[TBL] [Abstract][Full Text] [Related]
5. [Action of drugs tested in an acellular medium and in mice infected with Trypanosoma brucei brucei].
Bouteille B; Darde ML; Pestre-Alexandre M
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):533-42. PubMed ID: 3143489
[TBL] [Abstract][Full Text] [Related]
6. Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study.
Poltera AA; Hochmann A; Lambert PH
Clin Exp Immunol; 1981 Nov; 46(2):363-74. PubMed ID: 7039886
[TBL] [Abstract][Full Text] [Related]
7. The treatment of Trypanosoma (Nannomonas) simiae in pigs with diminazene aceturate in combination with a 5-substituted 2-nitroimidazole compound (Ro 15-0216).
Zweygarth E; Röttcher D
Trop Med Parasitol; 1987 Sep; 38(3):175-6. PubMed ID: 3432952
[TBL] [Abstract][Full Text] [Related]
8. An alternative form of melarsoprol in sleeping sickness.
Kennedy PG
Trends Parasitol; 2012 Aug; 28(8):307-10. PubMed ID: 22704910
[TBL] [Abstract][Full Text] [Related]
9. In vivo evaluation of sixteen plant extracts on mice inoculated with Trypanosoma brucei gambiense.
Youan BB; Coulibaly S; Miezan TB; Doua F; Bamba M
Bull World Health Organ; 1997; 75(4):343-8. PubMed ID: 9342893
[TBL] [Abstract][Full Text] [Related]
10. Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness.
Kaiser M; Bray MA; Cal M; Bourdin Trunz B; Torreele E; Brun R
Antimicrob Agents Chemother; 2011 Dec; 55(12):5602-8. PubMed ID: 21911566
[TBL] [Abstract][Full Text] [Related]
11. Cynaropicrin: the first plant natural product with in vivo activity against Trypanosoma brucei.
Zimmermann S; Kaiser M; Brun R; Hamburger M; Adams M
Planta Med; 2012 Apr; 78(6):553-6. PubMed ID: 22331812
[TBL] [Abstract][Full Text] [Related]
12. Fexinidazole: A New Drug for African Sleeping Sickness on the Horizon.
Pollastri MP
Trends Parasitol; 2018 Mar; 34(3):178-179. PubMed ID: 29275007
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of Grammomys surdaster thicket rats to Trypanosoma brucei gambiense infection.
Büscher P; Bin Shamamba SK; Ngoyi DM; Pyana P; Baelmans R; Magnus E; Van Overmeir C
Trop Med Int Health; 2005 Sep; 10(9):850-5. PubMed ID: 16135191
[TBL] [Abstract][Full Text] [Related]
14. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
Mesu VKBK; Kalonji WM; Bardonneau C; Mordt OV; Blesson S; Simon F; Delhomme S; Bernhard S; Kuziena W; Lubaki JF; Vuvu SL; Ngima PN; Mbembo HM; Ilunga M; Bonama AK; Heradi JA; Solomo JLL; Mandula G; Badibabi LK; Dama FR; Lukula PK; Tete DN; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
Lancet; 2018 Jan; 391(10116):144-154. PubMed ID: 29113731
[TBL] [Abstract][Full Text] [Related]
15. Suggested dosage rates of melarsoprol in the treatment of mice experimentally infected with Trypanosoma brucei gambiense.
Mbati PA; Hirumi K; Inoue N; Situakibanza NH; Hirumi H
Onderstepoort J Vet Res; 2000 Mar; 67(1):71-4. PubMed ID: 10843325
[TBL] [Abstract][Full Text] [Related]
16. Preliminary efficacy trial of Cymelarsan in mice artificially infected with Trypanosoma brucei brucei isolated from a dog in Zambia.
Syakalima M; Yasuda J; Hashimoto A
Jpn J Vet Res; 1995 Sep; 43(2):93-7. PubMed ID: 7474644
[TBL] [Abstract][Full Text] [Related]
17. Eflornithine for the treatment of human African trypanosomiasis.
Burri C; Brun R
Parasitol Res; 2003 Jun; 90 Supp 1():S49-52. PubMed ID: 12811548
[TBL] [Abstract][Full Text] [Related]
18. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P
J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469
[TBL] [Abstract][Full Text] [Related]
19. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U
Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225
[TBL] [Abstract][Full Text] [Related]
20. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
